Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide

BACKGROUND: Patients with acute-onset symptomatic atrial fibrillation (AF) can be treated with flecainide. However, flecainide may induce arrhythmias and/or exaggerate heart failure. Therefore, validated markers to predict the efficacy of flecainide and prevent adverse effects are required. We hypot...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Ahmad Shoaib, Peters, René H.J., Verstraaten, Maaike, Wilde, Arthur A.M., Buijs, Eugène M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2015
Materias:
Design Study Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352147/
https://www.ncbi.nlm.nih.gov/pubmed/25884086
http://dx.doi.org/10.1007/s12471-015-0659-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352147/
https://www.ncbi.nlm.nih.gov/pubmed/25884086
http://dx.doi.org/10.1007/s12471-015-0659-8

Ejemplares similares